It was suggested that the concurrent pro-fibrotic effect of IL-33 might be mediated by induction of IL-13 expression in ILC2 [170] as shown in murine models of hepatic fibrosis, in which ILC2-derived IL-13 activated HSC, the key drivers of hepatic fibrosis [166]. This evidence concerns the gene IL33 and Hepatic fibrosis.